血栓性微血管病
非典型溶血尿毒综合征
医学
伊库利珠单抗
溃疡性结肠炎
发病机制
炎症性肠病
免疫学
溶血性贫血
补体系统
疾病
并发症
内科学
抗体
作者
Javier Francisco Viada Bris,Marta Velasco Rodríguez‐Belvís,Carmen de Lucas Collantes,Cristina Aparicio López,Amelia Martínez de Azagra,Gema De Lama Caro‐Patón,Inmaculada de Prada Vicente,Rosa Ana Muñoz Codoceo
摘要
Hemolytic-uremic syndrome (HUS) is defined as the triad of nonimmune hemolytic anemia, thrombocytopenia, and acute renal failure, in which the underlying lesions are mediated by systemic thrombotic microangiopathy (TMA). The atypical HUS (aHUS) can be considered a subtype of HUS that is rare in childhood and has a worse prognosis. Recent findings have established that the TMA in aHUS are consequences of the disregulation of the complement activation, leading to endotelial damage mediated by the complement terminal pathway.1, 2 Likewise, previous research suggests an important role for the deregulation of the alternative complement cascade in the pathogenesis of inflammatory bowel disease (IBD).3, 4 We report the case of a patient with ulcerative colitis (UC) who developed aHUS during a flare-up of her chronic disease. This association is extremely infrequent and had been previously reported in only 1 patient.5.
科研通智能强力驱动
Strongly Powered by AbleSci AI